Article

When worlds converge: How Most-Favored-Nation policy and International Reference Pricing reshape global market access interdependencies

  • Erika Wissinger

  • David Ringger, PHD

  • Casper Paardekooper

  • Diane Smith

This article was originally published on ISPOR

Global drug pricing decisions do not happen in isolation

This article explores how most favored nation policies and international reference pricing are reshaping global market access by linking pricing, reimbursement, and launch decisions across markets. It highlights why manufacturers need a more coordinated strategy to anticipate downstream effects on pricing, access, and commercialization. 

Click below to read the full article today.

Nous sommes là pour vous aider

Contactez notre équipe dès aujourd’hui pour en savoir plus sur la façon dont Cencora contribue à façonner l’avenir des soins de santé.

Ressources connexes

Webinaire

The first Joint Clinical Assessment is here: What market access teams should learn now

Guide

Le guide essentiel pour la commercialisation des médicaments

Webinaire

Le potentiel transformateur de l’IA dans l’HEOR et l’accès au marché